Mutual Fund Ownership
Ownership as on: Fri, 19 Jul, 2024

Kotak Healthcare Fund Regular Growth

NA
Equity
Amount Invested (Cr.)8.75
% of AUM2.84%

UTI Healthcare Fund Regular Plan Growth

NA
Equity
Amount Invested (Cr.)14.28
% of AUM1.45%

UTI Small Cap Fund Regular Growth

2/5
Equity
Amount Invested (Cr.)45.41
% of AUM1.08%

UTI Large & Mid Cap Fund Regular Plan Growth

3/5
Equity
Amount Invested (Cr.)27.05
% of AUM0.79%

UTI Aggressive Hybrid Fund Regular Plan Growth

4/5
Hybrid
Amount Invested (Cr.)41.19
% of AUM0.70%

FAQs about Marksans Pharma share price

Marksans Pharma is trading at 185.15 as on Fri Jul 19 2024 10:26:54. This is -2.17% lower as compared to its previous closing price of 189.25.

The market capitalization of Marksans Pharma is 8390.33 Cr as on Fri Jul 19 2024 10:26:54.

The 52 wk high for Marksans Pharma is 197.25 whereas the 52 wk low is 93.85

Marksans Pharma can be analyzed on the following key metrics -

  • TTM P/E: 21.92
  • Sector P/E: 30.83
  • Dividend Yield: 0.32%
  • D/E ratio: 0.12

Marksans Pharma reported a net profit of 313.70 Cr in 2024.

Recommended For You
Trending Stocks
1,792.85+33.70(1.92%)
474.30+4.20(0.89%)
2,945.95+15.50(0.53%)
157.75-8.60 (-5.17%)
364.50-13.25 (-3.51%)
HomeMarketsPremiumInstant LoanBudget